Sponsored by: Sanofi Genzyme
Skin cancer includes two large groups: cutaneous melanoma and nonmelanoma skin cancer (NMSC).
At the start of the 21st Century, melanoma remains a potentially fatal malignancy, accounting for 75% of all deaths from skin cancer. At a time when the incidence of many tumour types is decreasing, melanoma incidence continues to increase. Although most patients have localised disease at the time of the diagnosis and are treated by surgical excision of the primary tumour, many patients develop metastases.
Nonmelanoma skin cancer (NMSC) is the most common form of cancer in the world and approximately 40% of all malignancies. The incidence of nonmelanoma skin cancer has increased since the 1990s, but its mortality rate has decreased.
Once you complete the resource - and achieve the minimum pass rate of 60% - you'll be awarded with a downloadable one hour CPD Certificate, which you can print or upload to your CPD Portfolio.
This module is composed of 10 assessment questions on skin cancer. On successful completion of this resource, you should gain an improved understanding of:
You may also be interested in some of the other CPD courses we provide, which are similar to our Skin Cancer CPD module:
Available all year round with 24/7 online access and unlimited resists, you'll be able to learn around your busy schedule and get to grips with your CPD modules whenever and wherever you’d like - all you need is an internet connection!
Our CPD modules are written and edited by medical experts within their specialist fields, who have pedigrees in postgraduate education. Questions are reviewed on a regular basis to ensure that they remain relevant and up-to-date with new guidelines.
As a healthcare professional it's important for you to continuously expand on your clinical knowledge, skills and abilities. Our CPD modules will help you achieve this by providing you with a full explanation of answers, further reading, and the option to reflect using our online notes system.